Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Astellas
Astellas
Astellas' menopause drug suffers rare setback as failed Asian trial blots previously pristine record
Fierce Biotech
Tue, 03/15/22 - 10:41 am
Astellas
menopause
hot flashes
clinical trials
fezolinetant
Astellas’ eyes filings for menopause drug fezolinetant after ph3 win
Pharmaforum
Mon, 03/7/22 - 10:07 am
Astellas
menopause
clinical trials
fezolinetant
hot flashes
March-in campaign on Pfizer's prostate cancer med Xtandi gets congressional backing. Will it matter?
Fierce Pharma
Tue, 02/22/22 - 11:17 pm
Pfizer
Astellas
prostate cancer
Xtandi
NIH
Trial win sets up new use for Astellas, Seagen’s Padcev in bladder cancer
Pharmaforum
Mon, 02/14/22 - 11:44 pm
Astellas
Seagen
Padcev
bladder cancer
clinical trials
Astellas becomes latest Dyno gene therapy partner with $1.6B biobucks pact to join Roche, Novartis, Sarepta
Fierce Biotech
Wed, 12/1/21 - 11:51 pm
Astellas
Dyno Therapeutics
biobucks
gene therapy
ESMO: Pfizer, Astellas' latest Xtandi survival data may shore up prostate cancer lead over J&J
Fierce Pharma
Sat, 09/18/21 - 08:26 pm
ESMO
Pfizer
Astellas
Xtandi
prostate cancer
clinical trials
Astellas readies roxadustat for launch
EP Vantage
Wed, 09/15/21 - 10:37 am
Astellas
roxadustat
drug launches
Astellas reports fourth death in halted gene therapy trial
Pharmaforum
Tue, 09/14/21 - 10:59 am
Astellas
gene therapy
AT132
patient deaths
clinical trials
X-linked myotubular myopathy
More trouble for Astellas as AT132 gene therapy trial is halted again
Pharmaforum
Wed, 09/1/21 - 11:02 am
Astellas
gene therapy
AT132
clinical trials
X-linked myotubular myopathy
After FDA snub, EMA backs FibroGen, Astellas’ roxadustat
Pharmaforum
Fri, 08/20/21 - 10:51 am
Europe
FibroGen
Astellas
Evrenzo
anemia
chronic kidney disease
FDA Approvals Roundup: Kerendia, Padcev, Darzalex Faspro
RAPS.org
Thu, 07/15/21 - 12:34 pm
FDA
drug approvals
Bayer
Kerendia
Astellas
Padcev
Teva Pharmaceutical
ArmonAir RespiClick
Janssen
Darzalex Faspro
Pneumococcal Vaccine Snags Breakthrough Therapy Designation
BioSpace
Tue, 07/13/21 - 11:29 pm
Astellas
Affinivax
vaccines
pneumococcal disease
breakthrough therapy
Seagen, Astellas' Padcev snares full approval and expands into second-line treatment on path to blockbuster land
Fierce Pharma
Sat, 07/10/21 - 12:00 am
Astellas
Seagen
Padcev
FDA
bladder cancer
The big approvals still on the cards for 2021
EP Vantage
Thu, 06/17/21 - 11:00 am
FDA
drug approvals
Argenx
Novartis
AstraZeneca
Astellas
UCB Pharma
Ascendis Pharma
ChemoCentryx
Axsome Therapeutics
#ASCO21: Ahead of August PDUFA date, Astellas and Seagen sweeten Padcev pitch with new data
Endpoints
Thu, 05/20/21 - 12:16 pm
ASCO 2021
Astellas
Seagen
Padcev
FDA
urothelial cancer
Astellas quietly cuts Cytokinetics R&D pact as $450M-plus in biobucks goes up in smoke
Fierce Biotech
Mon, 05/3/21 - 10:51 am
Astellas
Cytokinetics
biobucks
Astellas takes $540M impairment charge over Audentes' gene therapy trial hold
Fierce Biotech
Tue, 04/27/21 - 10:47 am
Astellas
Audentes
AT132
gene therapy
Astellas innovation awards offer up ideas to ease cancer patients' pandemic burdens
Fierce Pharma
Tue, 04/20/21 - 07:36 pm
Astellas
cancer
innovation
Seagen gets August PDUFA for Padcev expansions
Endpoints
Mon, 04/19/21 - 10:25 pm
Seagen
FDA
Padcev
Astellas
Nearly a year after Audentes' gene therapy deaths, the trial continues. What happened remains a mystery
Endpoints
Wed, 04/14/21 - 09:37 am
Audentes
Astellas
gene therapy
clinical trials
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »